Sign in
Explore the registryTrack Olaparib 300mg's trials

SOLO-1

Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.

Olaparib 300mg tabletsOngoingActive not recruitingPhase 3Open NCT01844986 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…